SONDER HOLDINGS INC (SOND)

US83542D3008 - Common Stock

3.46  +0.28 (+8.81%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to SOND. SOND was compared to 133 industry peers in the Hotels, Restaurants & Leisure industry. SOND has a bad profitability rating. Also its financial health evaluation is rather negative. SOND is quite expensive at the moment. It does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

In the past year SOND has reported negative net income.
SOND had a negative operating cash flow in the past year.
In the past 5 years SOND always reported negative net income.
In the past 5 years SOND always reported negative operating cash flow.

1.2 Ratios

SOND's Return On Assets of -15.01% is on the low side compared to the rest of the industry. SOND is outperformed by 93.08% of its industry peers.
Industry RankSector Rank
ROA -15.01%
ROE N/A
ROIC N/A
ROA(3y)-76.07%
ROA(5y)-93.72%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of SOND (50.01%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of SOND has declined.
SOND does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-27.04%
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

SOND does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SOND has been increased compared to 1 year ago.
Compared to 1 year ago, SOND has a worse debt to assets ratio.

2.2 Solvency

SOND has an Altman-Z score of -1.81. This is a bad value and indicates that SOND is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -1.81, SOND is not doing good in the industry: 95.38% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.81
ROIC/WACCN/A
WACC3.8%

2.3 Liquidity

SOND has a Current Ratio of 0.29. This is a bad value and indicates that SOND is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of SOND (0.29) is worse than 93.85% of its industry peers.
A Quick Ratio of 0.29 indicates that SOND may have some problems paying its short term obligations.
SOND has a Quick ratio of 0.29. This is amonst the worse of the industry: SOND underperforms 83.85% of its industry peers.
Industry RankSector Rank
Current Ratio 0.29
Quick Ratio 0.29

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 35.66% over the past year.
The Revenue has grown by 15.74% in the past year. This is quite good.
SOND shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 73.29% yearly.
EPS 1Y (TTM)35.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%170.6%
Revenue 1Y (TTM)15.74%
Revenue growth 3Y73.29%
Revenue growth 5YN/A
Sales Q2Q%4.57%

3.2 Future

Based on estimates for the next years, SOND will show a very negative growth in Earnings Per Share. The EPS will decrease by -120.66% on average per year.
SOND is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.66% yearly.
EPS Next Y-693.1%
EPS Next 2Y-120.66%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year24.55%
Revenue Next 2Y21.03%
Revenue Next 3Y19.35%
Revenue Next 5Y16.66%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

0

4. Valuation

4.1 Price/Earnings Ratio

SOND reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SOND. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A cheap valuation may be justified as SOND's earnings are expected to decrease with -120.66% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-120.66%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for SOND!.
Industry RankSector Rank
Dividend Yield N/A

SONDER HOLDINGS INC

NASDAQ:SOND (1/2/2025, 3:12:38 PM)

3.46

+0.28 (+8.81%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)11-22 2024-11-22
Earnings (Next)N/A N/A
Inst Owners33.15%
Inst Owner Change36.32%
Ins Owners2.14%
Ins Owner Change0%
Market Cap40.10M
Analysts43.33
Price Target4.08 (17.92%)
Short Float %8.73%
Short Ratio9.48
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-17.33%
Min Revenue beat(2)-18.15%
Max Revenue beat(2)-16.5%
Revenue beat(4)0
Avg Revenue beat(4)-11.44%
Min Revenue beat(4)-18.15%
Max Revenue beat(4)-5.15%
Revenue beat(8)2
Avg Revenue beat(8)-5.71%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.06
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-16.55
EYN/A
EPS(NY)-6.83
Fwd EYN/A
FCF(TTM)-10.96
FCFYN/A
OCF(TTM)-10.62
OCFYN/A
SpS53.67
BVpS-33.42
TBVpS-33.42
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.01%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 50.01%
FCFM N/A
ROA(3y)-76.07%
ROA(5y)-93.72%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-27.04%
GM growth 5YN/A
F-Score4
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 20.22%
Cap/Sales 0.62%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.29
Quick Ratio 0.29
Altman-Z -1.81
F-Score4
WACC3.8%
ROIC/WACCN/A
Cap/Depr(3y)85.74%
Cap/Depr(5y)106.16%
Cap/Sales(3y)4.94%
Cap/Sales(5y)8.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%170.6%
EPS Next Y-693.1%
EPS Next 2Y-120.66%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)15.74%
Revenue growth 3Y73.29%
Revenue growth 5YN/A
Sales Q2Q%4.57%
Revenue Next Year24.55%
Revenue Next 2Y21.03%
Revenue Next 3Y19.35%
Revenue Next 5Y16.66%
EBIT growth 1Y23.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year52.52%
EBIT Next 3Y34.44%
EBIT Next 5Y24.08%
FCF growth 1Y57.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y54.2%
OCF growth 3YN/A
OCF growth 5YN/A